연구동향 분석

기능성 소화불량증의 최근 동향

박종규 ( Jong Kyu Park ) 허규찬 ( Kyu Chan Huh ) 신철민 ( Cheol Min Shin ) 이혁 ( Hyuk Lee ) 윤영훈 ( Young Hoon Yoon ) 송경호 ( Kyung Ho Song ) 민병훈 ( Byung Hoon Min ) 최기돈 ( Kee Don Choi ) 2014년

논문상세정보
인용/피인용
' 기능성 소화불량증의 최근 동향' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • diagnosis
  • functional dyspepsia
  • helicobacter pylori
  • sleep disorder
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
678 0

0.0%

' 기능성 소화불량증의 최근 동향' 의 참고문헌

  • 한국인의 기능성 위장 장애의 진단에 있어서 로마기준 Ⅲ의 유용성
    김익성 Journal of Neurogastroenterology and Motility (JNM) 14 (1) : 39 ~ 44 [2008]
  • 기능성 소화불량증 치료에 관한 임상진료지침
    지삼룡 대한소화기학회지 57 (2) : 67 ~ 81 [2011]
  • 기능성 소화 불량증 및 과민성 장 증후군 환자에서 세로토닌 수송 단백질 유전자와 GNβ3 C825T 유전자의 다형성
    박혜연 Journal of Neurogastroenterology and Motility (JNM) 15 (1) : 58 ~ 64 [2009]
  • What Is the Difference Between Helicobacter pylori- Associated Dyspepsia and Functional Dyspepsia?
    Hidekazu Suzuki Journal of Neurogastroenterology and Motility (JNM) 17 (2) : 124 ~ 130 - [2011]
  • U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact
    Drossman DA Dig Dis Sci 38 : 1569 ~ 1580 - [1993]
  • Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review
    Hojo M J Gastroenterol 40 : 1036 ~ 1042 - [2005]
  • Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography
    Kusunoki H Neurogastroenterol Motil 24 : 240 ~ 251 [2012]
  • The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria
    Wang A BMC Gastroenterol 8 : 43 ~ - [2008]
  • The Rome III criteria for the diagnosis of functional dyspepsia in secondary care are not superior to previous definitions
    Ford AC Gastroenterology 146 : 932 ~ 940 - [2014]
  • The G-protein beta3 subunit 825 TT genotype is associated with epigastric pain syndrome- like dyspepsia
    Oshima T BMC Med Genet 11 : 13 ~ - [2010]
  • Tegaserod treatment for dysmotility- like functional dyspepsia: results of two randomized, controlled trials
    Vakil N Am J Gastroenterol 103 : 1906 ~ 1919 - [2008]
  • Sleep dysfunction in patients with GERD: erosive versus nonerosive reflux disease
    Yi CH Am J Med Sci 334 : 168 ~ 170 - [2007]
  • Silent peptic ulcer disease: frequency, factors leading to 'silence,' and implications regarding the pathogenesis of visceral symptoms
    Lu CL Gastrointest Endosc 60 : 34 ~ 38 - [2004]
  • Should We Still Subcategorize Helicobacter pylori- Associated Dyspepsia as Functional Disease?
    Kentaro Sugano Journal of Neurogastroenterology and Motility (JNM) 17 (4) : 366 ~ 371 - [2011]
  • Rome III subgroups of functional dyspepsia exhibit different characteristics of antral contractions measured by strain rate imaging: a pilot study
    Ahmed AB Ultraschall Med 33 : E233 ~ E240 [2012]
  • Role of impaired gastric accommodation to a meal in functional dyspepsia
    Tack J Gastroenterology 115 : 1346 ~ 1352 - [1998]
  • Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite
    Akamizu T Eur J Endocrinol 158 : 491 ~ 498 - [2008]
  • Relation among plasma ghrelin level, gastric emptying, and psychologic condition in patients with functional dyspepsia
    Takamori K J Clin Gastroenterol 41 : 477 ~ 483 - [2007]
  • Randomised clinical trial:the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study
    Braak B Aliment Pharmacol Ther 34 : 638 ~ 648 [2011]
  • Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is ther apeutic response predicted by Rome III subgroups?
    Hsu YC J Gastroenterol 46 : 183 ~ 190 - [2011]
  • Prokinetics and fundic relaxants in upper functional GI disorders
    Tack J Curr Opin Pharmacol 8 : 690 ~ 696 - [2008]
  • Prevalence of uninvestigated dyspepsia and gastroesophageal reflux disease in Korea: a population-based study using the Rome III criteria
    Min BH Dig Dis Sci [2014]
  • Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria
    Xiao YL Am J Gastroenterol 105 : 2626 ~ 2631 - [2010]
  • Prevalence and risk factors of asymptomatic peptic ulcer disease in Taiwan
    Wang FW World J Gastroenterol 17 : 1199 ~ 1203 - [2011]
  • Predominant symptom behavior in patients with persistent dyspepsia during treatment
    Laheij RJ J Clin Gastroenterol 38 : 490 ~ 495 - [2004]
  • Predictors of the placebo response in functional dyspepsia
    Talley NJ Aliment Pharmacol Ther 23 : 923 ~ 936 - [2006]
  • Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia
    Kok-Ann Gwee Journal of Neurogastroenterology and Motility (JNM) 16 (1) : 30 ~ 34 [2010]
  • Polymorphisms of the Serotonin Transporter Gene and G-Protein β3 Subunit Gene in Korean Children with Irritable Bowel Syndrome and Functional Dyspepsia
    Cheong Soo Park Gut and Liver 6 (2) : 223 ~ 228 - [2012]
  • Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility- like functional dyspepsia
    Lee KJ Digestion 80 : 58 ~ 63 - [2009]
  • Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis
    McCallum RW Neurogastroenterol Motil 25 : e705 ~ e717 - [2013]
  • Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study
    Talley NJ Clin Gastroenterol Hepatol 5 : 1175 ~ 1183 - [2007]
  • Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying
    Futagami S Digestion 86 : 114 ~ 121 - [2012]
  • Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association
    Shaker R Am J Gastroenterol 98 : 1487 ~ 1493 - [2003]
  • Nationwide epidemiological study on gastroesophageal reflux disease and sleep disorders in the Japanese population
    Kusano M J Gastroenterol 43 : 833 ~ 841 - [2008]
  • Migration of eosinophils and CCR2-/CD68-double positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia
    Futagami S Am J Gastroenterol 105 : 1835 ~ 1842 - [2010]
  • Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review
    Henningsen P Psychosom Med 65 : 528 ~ 533 - [2003]
  • Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double- blind, placebo-controlled trials
    Talley NJ Gut 57 : 740 ~ 746 - [2008]
  • Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia?
    Haag S Neurogastroenterol Motil 22 : 262 ~ 279 - [2010]
  • Influence of erythromycin on gastric emptying and meal related symptoms in functional dys pepsia with delayed gastric emptying
    Arts J Gut 54 : 455 ~ 460 - [2005]
  • Inflammation, immunity, and vaccines for Helicobacter pylori
    D'Elios MM Helicobacter 14 (1) : 21 ~ 28 - [2009]
  • Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori
    Osawa H J Clin Endocrinol Metab 90 : 10 ~ 16 - [2005]
  • Impact of sleep disorders in Japanese patients with functional dyspepsia (FD): nizatidine improves clinical symptoms, gastric emptying and sleep disorders in FD patients
    Futagami S J Gastroenterol Hepatol 28 : 1314 ~ 1320 - [2013]
  • Impact of Sleep Disorders, Quality of Life and Gastric Emptying in Distinct Subtypes of Functional Dyspepsia in Japan
    Hiroshi Yamawaki Journal of Neurogastroenterology and Motility (JNM) 20 (1) : 104 ~ 112 - [2014]
  • Helicobacter pylori eradication in functional dyspepsia:HEROES trial
    Mazzoleni LE Arch Intern Med 171 : 1929 ~ 1936 - [2011]
  • Helicobacter pylori CagA protein variation associated with gastric cancer in Asia
    Azuma T J Gastroenterol 39 : 97 ~ 103 - [2004]
  • Health-related quality of life in functional dyspepsia
    El-Serag HB Aliment Pharmacol Ther 18 : 387 ~ 393 - [2003]
  • Gut hormones and appetite control
    Wren AM Gastroenterology 132 : 2116 ~ 2130 - [2007]
  • Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains
    Yamaoka Y Intern Med 47 : 1077 ~ 1083 [2008]
  • Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis
    Liu Y J Clin Pathol 58 : 927 ~ 931 - [2005]
  • G-protein 3 subunit 825CC genotype is associated with postprandial distress syndrome with impaired gastric emptying and with the feeling of hunger in Japanese
    Shimpuku M Neurogastroenterol Motil 23 : 1073 ~ 1080 - [2011]
  • G-Protein Beta3 Subunit C825T Polymorphism in Patients With Overlap Syndrome of Functional Dyspepsia and Irritable Bowel Syndrome
    Han Gyeol Kim Journal of Neurogastroenterology and Motility (JNM) 18 (2) : 205 ~ 210 - [2012]
  • Functional gastroduodenal disorders
    Tack J Gastroenterology 130 : 1466 ~ 1479 - [2006]
  • Functional gastroduodenal disorders
    Talley NJ Gut 45 (2) : 37 ~ 42 - [1999]
  • Functional dyspepsia: past, present, and future
    Geeraerts B J Gastroenterol 43 : 251 ~ 255 - [2008]
  • Functional dyspepsia is associated with sleep disorders
    Lacy BE Clin Gastroenterol Hepatol 9 : 410 ~ 414 - [2011]
  • Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea
    박재명 Journal of Neurogastroenterology and Motility (JNM) 17 (3) : 279 ~ 286 [2011]
  • Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study
    Zagari RM Gastroenterology 138 : 1302 ~ 1311 - [2010]
  • Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial
    Miwa H Am J Gastroenterol 104 : 2779 ~ 2787 - [2009]
  • Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia
    Tack J Clin Gastroenterol Hepatol 10 : 1239 ~ 1245 - [2012]
  • Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia
    Read NW Gut 41 : 664 ~ 668 - [1997]
  • Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial
    van Kerkhoven LA Clin Gastroenterol Hepatol 6 : 746 ~ 752 [2008]
  • Effect of sleep quality on symptoms of irritable bowel syndrome
    Goldsmith G Dig Dis Sci 38 : 1809 ~ 1814 [1993]
  • Economic costs of functional dyspepsia
    Nyrén O Pharmacoeconomics 1 : 312 ~ 324 [1992]
  • Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings
    Piessevaux H Neurogastroenterol Motil 21 : 378 ~ 388 - [2009]
  • Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice
    Saito Y Gastroenterology 140 : 189 ~ 198 - [2011]
  • Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia
    Walker MM Aliment Pharmacol Ther 29 : 765 ~ 773 - [2009]
  • Duodenal eosinophilia and early satiety in functional dyspepsia: confirmation of a positive association in an Australian cohort
    Walker MM J Gastroenterol Hepatol 29 : 474 ~ 479 - [2014]
  • Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study
    Hallerbäck BI Aliment Pharmacol Ther 16 : 959 ~ 967 - [2002]
  • Discriminant value of Rome III questionnaire in dyspeptic patients
    Abid S Saudi J Gastroenterol 17 : 129 ~ 133 - [2011]
  • Development and Validation of the Korean Rome IIIQuestionnaire for Diagnosis of Functional Gastrointestinal Disorders
    송경호 Journal of Neurogastroenterology and Motility (JNM) 19 (4) : 509 ~ 515 [2013]
  • Current status of functional dyspepsia in Korea
    이혁 The Korean Journal of Internal Medicine 29 (2) : 156 ~ 165 [2014]
  • Current management strategies and emerging treatments for functional dyspepsia
    Camilleri M Nat Rev Gastroenterol Hepatol 10 : 187 ~ 194 - [2013]
  • Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms
    Vakil N Clin Gastroenterol Hepatol 7 : 756 ~ 761 - [2009]
  • Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease
    Shindo T Digestion 79 : 65 ~ 72 - [2009]
  • Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia: 100 mg t.i.d. is an optimal dosage
    Matsueda K Neurogastroenterol Motil 22 : 618 ~ 673 - [2010]
  • Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis
    Kawashima J J Gastroenterol 44 : 1046 ~ 1054 - [2009]
  • Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia?
    Suzuki H J Gastroenterol Hepatol 26 (3) : 42 ~ 45 - [2011]
  • Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia
    Karamanolis G Gastroenterology 130 : 296 ~ 303 - [2006]
  • Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia
    Talley NJ Aliment Pharmacol Ther 27 : 1122 ~ 1131 - [2008]
  • Asian consensus report on functional dyspepsia
    Miwa H J Gastroenterol Hepatol 27 : 626 ~ 641 - [2012]
  • Asian Consensus Report on Functional Dyspepsia
    Hiroto Miwa Journal of Neurogastroenterology and Motility (JNM) 18 (2) : 150 ~ 168 - [2012]
  • Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study
    Aro P Gastroenterology 137 : 94 ~ 100 - [2009]
  • American gastroenterological association technical review on the evaluation of dyspepsia
    Talley NJ Gastroenterology 129 : 1756 ~ 1780 [2005]
  • Acute gastroenteritis and the risk of functional dyspepsia: a systematic review and meta-analysis
    Pike BL Am J Gastroenterol 108 : 1558 ~ 1563 - [2013]
  • A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia
    Matsueda K Gut 61 : 821 ~ 828 - [2012]
  • A placebo- controlled trial of itopride in functional dyspepsia
    Holtmann G N Engl J Med 354 : 832 ~ 840 - [2006]
  • A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia
    Tack J Neurogastroenterol Motil 21 : 272 ~ 280 - [2009]
  • A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia
    Castillo EJ Clin Gastroenterol Hepatol 2 : 985 ~ 996 - [2004]
  • A Rome III survey of functional dyspepsia among the ethnic Malays in a primary care setting
    Lee YY BMC Gastroenterol 13 : 84 ~ - [2013]